Skip to content

Effects of Smoking on Non-surgical Periodontal Therapy in Generalized Aggressive Periodontitis

Effects of Smoking on Non-surgical Periodontal Therapy in Generalized Aggressive Periodontitis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03512938
Enrollment
27
Registered
2018-05-01
Start date
2014-06-23
Completion date
2017-09-28
Last updated
2018-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized Aggressive Periodontitis, Smoking

Keywords

Generalized aggressive periodontitis, Non-surgical periodontal therapy, Periodontopathogens, Smoking, Gingival crevicular fluid

Brief summary

Smoking is the major preventable risk factor in the initiation and progression of periodontal diseases. Periodontitis risk was found to be 3.9 times higher among smokers aged between 19-30 years and 2.8 times higher among smokers aged 31-40 years compared to non-smokers. Aggressive periodontitis (AgP), is characterized by a rapid attachment loss usually incompatible with the amount of plaque and dental calculus. It is often not possible to predict the prognosis of treatment with various treatment options in cases of aggressive periodontitis. It was hypothesized that non-smoker patients with generalized aggressive periodontitis (GAgP) will respond better to conventional mechanical non-surgical periodontal therapy compared to the smokers. Therefore, the aim of this study was to evaluate the effects of smoking on the outcomes of non-surgical periodontal treatment in terms of the clinical, biochemical and microbiological parameters.

Interventions

PROCEDURENon-surgical periodontal therapy

Patients were motivated and instructed to brush with modified Bass technique and use interdental toothbrushes, dental floss. Each patient underwent quadrant scaling and root planning (SRP) under local anaesthesia over a 4-week period. Root planing (RP) was performed under local anaesthesia (2% lidocaine, epinephrine 1:100.000) and a standard curette set newly sharpened with Arkansas stone was used for each patient.

Sponsors

University of Glasgow
CollaboratorOTHER
Ege University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Having at least six permanent teeth, including incisors and/or first molars with severe periodontal disease * Having at least one site with probing depth (PD) and clinical attachment level (CAL) ≥5 mm and six teeth other than first molars and incisors with similar PD and CAL measurements * Familial aggregation

Exclusion criteria

* Medical disorders such as diabetes mellitus, immunological disorders * Having an antibiotic or periodontal treatment in the last 6 months * Having \<15 teeth

Design outcomes

Primary

MeasureTime frame
Change in Clinical Attachment Level (CAL)Baseline and 1 month, 3 month, 6 month after non-surgical periodontal therapy

Secondary

MeasureTime frameDescription
Change in Bleeding on Probing (BoP)Baseline and 1 month, 3 month, 6 month after non-surgical periodontal therapy
Change in Plaque Index (PI)Baseline and 1 month, 3 month, 6 month after non-surgical periodontal therapy
Changing of the salivary biomarkersBaseline and 1 month, 3 month, 6 month after non-surgical periodontal therapyIn the morning following an overnight fast, during which subjects were requested not to drink (except water) or to chew gum, whole saliva samples were obtained by expectorating into polypropylene tubes; clinical periodontal measurements and any necessary periodontal interventions were then carried out. Cytokine levels were assessed by Enzyme-linked immunosorbent assay (ELISA).
Change in Probing Depth (PD)Baseline and 1 month, 3 month, 6 month after non-surgical periodontal therapy
Changing of the gingival crevicular fluid (GCF) biomarkersBaseline and 1 month, 3 month, 6 month after non-surgical periodontal therapyGCF samples were obtained from buccal aspects of one interproximal site in each quadrant. Supragingival plaque was removed carefully by sterile curettes; the surfaces were dried and isolated by cotton rolls. Filter paper strips were placed in the orifices of the gingival sulcus/pocket for 30 seconds. Care was used to avoid mechanical trauma, and strips contaminated with blood were discarded. The absorbed GCF volume was estimated by a calibrated instrument. The readings of GCF sample volumes were converted to an actual volume (μL) by reference to the standard curve. Cytokine levels were assessed by Enzyme-linked immunosorbent assay (ELISA).
Changing of the amount of pathogen microorganismsBaseline and 1 month, 3 month, 6 month after non-surgical periodontal therapyPlaque samples were collected from the same sites by sterile paper points from the base of the pockets. Paper points were inserted into the deepest part of the pocket and kept for 5 seconds. Paper points were then placed into propylene tubes. Real-time polymerase chain reaction was used for detection and quantification of bacterial cell copy numbers in 1 mg plaque.
Changing of the serum biomarkersBaseline and 1 month, 3 month, 6 month after non-surgical periodontal therapyNine milliliters of venous blood were taken from the antecubital vein by a standard venipuncture method and centrifuged for 10 minutes at 3,000 rpm, separating serum from the cells. Cytokine levels were assessed by Enzyme-linked immunosorbent assay (ELISA).

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026